Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001797917-26-000007

Director acquired 13,786 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Prener Anne Director 2026-07-01 Grant or award +13,786 13,786 D
Derivatives
Prener Anne Director 2026-07-01 Grant or award · Stock Option (right to buy) +14,870 14,870 D
Loading xslF345X06/form4-07062026_080756.xml…